The Medicine and Ultrasound (MU) team combines expertise in ultrasound and medical imaging for both fundamental and clinical research. It innovates in acoustic and photoacoustic imaging, as well as in sono-activatable vectors, leveraging advanced equipment in ultrasound, biology, microbiology, biophysics, and microfluidics.

The MU team has two primary objectives. First, it is dedicated to discovering new biomarkers at the tissue, cellular, and vascular levels to enhance diagnostic capabilities, particularly in ultrasound, with a focus on the microscopic scale. In this regard, the team aims to extend its methods into three dimensions to eliminate quantitative biases. Second, it seeks to use ultrasound for tissue treatment, also concentrating on the microscopic scale.

With a vision of scientific breakthroughs, the MU team conducts fundamental in vitro studies and works to translate these innovative approaches into clinical applications. This effort builds on its past successes, such as contributions to Doppler imaging of the bone marrow and super-resolution ultrasound imaging for the brain and kidney.

The contribution of healthcare professionals within the MU team is of paramount importance. Clinicians ensure the clinical translation of research and guide the team’s scientific direction based on clinical needs and challenges. Adopting an ultrasound-based approach at the cellular scale will allow the MU team to surpass the limitations of macroscopic imaging. To achieve this, we have developed a broad range of expertise covering areas such as focused ultrasound systems, cellular and bacterial characterization, ultrafast 3D ultrasound imaging, photoacoustics, and an in-depth understanding of tissue biomechanics and ultrasound propagation. This comprehensive set of tools forms the foundation for creating new concepts designed for clinical translation.

The current projects of the MU team are given in the below links: